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Unusual Fibrosclerotic Lesion of the Laryngotracheal
Complex Presenting as Subglottic Stenosis
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We present a case report that describes the pathology, presentation, and management complexities of an unusual, destructive fibrosclerotic lesion of the laryngotracheal complex. An otherwise healthy 21-year-old man presented with a 1-year
history of progressive shortness of breath and stridor. The initial examination revealed a 3-cm, grade III subglottic stenosis. Nodular fibrosis of the strap muscles, laryngotracheal cartilages, and trachea was evident. Biopsies revealed dense
peritracheal desmoplastic reaction with focal erosion of cartilage. However, features diagnostic for relapsing polychondritis, desmoid tumor, or orbital pseudotumor were absent. The disease progressed to involve severe stenosis and thickening of the trachea and main stem bronchi. Surgical and medical management of this unusual fibrosclerotic lesion did not
ameliorate the disease process, but a recent encouraging response to tamoxifen citrate has been observed with improvements in vocal fold motion and activity levels. Prognosis and management experience for this unknown pathologic entity
are absent in the literature. In this case, diffuse disease progression occurred despite surgical and medical management,
but has been halted by tamoxifen therapy. The prospect of a durable response and disease remission is unknown.
Key Words: fibrosclerosis, relapsing polychondritis, subglottic stenosis, tumefactive fibroinflammatory lesion.

Subglottic stenosis is a rare entity in the absence
of a history of prior intubation, tracheotomy, or other airway instrumentation. Stenoses without a history of local trauma usually appear shortly after birth.
Disease processes known to cause idiopathic subglottic stenosis are mainly autoimmune in nature
and include relapsing polychondritis, sarcoidosis,
systemic lupus erythematosus, Wegener’s granulomatosis, Behçet’s syndrome, and other rare conditions. The mainstay of surgical treatment for these
entities is endoscopic laser treatment, dilation, and
tracheotomy for severe stenosis, whereas medical
therapies consist largely of systemic corticosteroids
and antimetabolites. Because of the unknown cause
of the disease process in the patient presented here,
the established treatment and prognosis have not
been defined. Continued disease progression to the
entire trachea in this case has essentially eliminated
surgical treatment options and focused the treating
physicians’ attention on medical treatment options.
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tution for this respiratory difficulty and had received
a diagnosis of asthma and had undergone treatment
with bronchodilators. To this point in time, he was
otherwise healthy and active. His history included
a 2-week intubation in infancy, but he recovered
uneventfully and had a healthy childhood without
other airway problems. He was stridorous on presentation, and nasopharyngolaryngoscopy revealed
a marginal airway and severely restricted vocal fold
motion. He promptly underwent fiberoptic intubation and tracheotomy with bronchoscopy. Tissues of
the larynx, trachea, thyroid, and strap muscles were
noted to be involved in a dense, nodular inflammatory process. Stenosis of the laryngeal inlet was
identified with an approximately 0.5-cm transverse
Cotton-Myer grade III subglottic stenosis (Fig 1).
The stenotic region widened as it extended distally
for approximately 3 cm, and computed tomography
revealed irregular tracheal calcification (Fig 2).
Tracheal biopsies displayed a dense peritracheal desmoplastic reaction and chronic inflammatory
infiltrate with focal erosion of cartilage (Fig 3). A
thyroid biopsy was characterized by a fibromyxoid
proliferation.
Rheumatologic consultation was obtained to aid
in medical management. Autoimmune serologic
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Introduction

Case REPORT

We present the case of a 21-year-old man who presented with a 1-year history of progressive shortness
of breath. He had been evaluated at an outside insti-
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Bronchoscopy with focused noncircumferential
lasering was performed along with 3 separate tracheal dilations over an 18-month period with only
short-lived improvements. Glottic and subglottic
stenosis persisted, and severe diffuse tracheal and
main stem bronchial thickening and stenosis were
noted during bronchoscopy and confirmed on repeat computed tomography scan. The patient became activity-restricted and could tolerate only mild
exertion. A second course of steroids and therapy
with the antimetabolite penicillamine achieved only
modest, transient improvements. At the time of initial presentation, the anterior-posterior tracheal di-

py
Co

DO

NO
TD

UP

testing was nondiagnostic (erythrocyte sedimentation rate, antinuclear antibody, anti–single-stranded DNA antibody, anti–double-stranded DNA antibody, anti-Smith antibody, anti–SS-A antibody,
anti–SS-B antibody, antineutrophil cytoplasmic antibody with cytoplasmic and perinuclear staining,
rheumatoid factor, and C-reactive protein). The patient was placed on a regimen of high-dose prednisone, and he initially responded to a 3-month course
with improved vocal fold mobility and improved
subglottic stenosis. As the steroid dosage was tapered, however, the clinical findings stabilized and
then worsened. The limited vocal fold motion was
thought to be a result of bilateral disease extension
to either the recurrent laryngeal nerves or the cri-

Fig 2. Tracheal stenosis and thickening extend distally
from subglottis.
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Fig 1. Subglottic narrowing shows Cotton-Myer stage III
stenosis.
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Fig 3. Tracheal biopsy shows erosion of
cartilage by chronic inflammatory infiltrate (short arrow), and fibromyxoid
change within adjacent soft tissue (long
arrow).
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also absent.3-7 An outside review of the pathologic
findings confirmed the unusual features of this lesion, but did not establish a firm diagnosis.
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Discussion

The response to tamoxifen may be secondary to
its antifibroblast activity.8 Additionally, estrogen receptors have been shown to be present in the human
trachea.9 Other fibroproliferative disease processes have responded favorably to tamoxifen therapy,
such as retroperitoneal fibrosis.10 Tamoxifen therapy will continue, along with serial visits and examinations, but further surgical management is not currently warranted. The patient may be a candidate for
transitioning to a T-tube for ease in care and to stent
the subglottis, but given the still-limited vocal fold
motion, decannulation is not an option.
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This unusual lesion is pathologically distinct from
previously described non-neoplastic diseases of the
laryngotracheal complex. Relapsing polychondritis
presents with tracheomalacia and inflammation with
pleomorphic lymphocytic infiltrate, which were not
characteristic of this lesion.1 Additionally, the lesion
did not exhibit the more cellular appearance of desmoid tumor.2 The prominent mononuclear infiltrate
of inflammatory pseudotumor and tumefactive fibroinflammatory lesions of the head and neck was
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Because this disease process is unrecognized, the
literature does not contain prognostic or therapeutic
experience. Initial hopes of decannulation after periods of disease response were not realized, because
of poor vocal fold motion and worsening stenosis.
Because the trachea has become diffusely involved,
including main stem bronchial thickening and narrowing, simple excision of the stenotic segment is
not an option. Serial lasering and dilations with the
addition of a topical agent to prevent rescarring,
such as the antimetabolite mitomycin C, are also
not feasible alternatives, because of the distal extent
of disease. The disease progression that occurred
through surgical management and trials of systemic
corticosteroids and penicillamine portended poorly
for future decannulation and normal activity levels.
The antiestrogen drug tamoxifen, however, has halted disease progression at this point and has afforded mildly improved vocal fold function and greatly
improved activity levels. The durability of this improvement remains to be seen, especially in light of
the persistent tracheal and main stem bronchial narrowing.
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ameter above the carina was approximately 1.6 cm
and the disease was limited to the glottis and subglottis. However, 17 months after the initial imaging, the anterior-posterior diameter above the carina
had narrowed to 8 mm.
Therapy with the antiestrogen agent tamoxifen
citrate was started approximately 8 months ago,
with rapid improvement in shortness of breath and
slightly improved vocal fold mobility. However,
acute worsening in shortness of breath 6 months ago
prompted operative flexible bronchoscopy that revealed granulation tissue at the site of the tracheotomy tube tip, which was relieved with flexible laser
treatment. Bronchoscopy showed continued severe
tracheal stenosis and worsening left main stem bronchial stenosis that would not permit the passage of
the 6-mm scope. The tamoxifen therapy was continued despite this relapse of symptoms, and referral to
a pulmonologist was made. Although the response
to the tamoxifen has not been consistent, the patient
remains on tamoxifen and, 8 months after initiation
of therapy, enjoys improved vocal fold motion and
greatly improved activity levels, such that he is once
again participating in recreational athletics. Curiously, recent bronchoscopy has not demonstrated
improvement in the tracheal or main stem bronchial
stenosis.
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